The Margins Are Outrageous
A pair of prescription eyeglasses — frames, lenses, coatings, the whole apparatus of corrected sight — costs no more than about £30 to manufacture. Top-of-the-range components, the best acetate and the most advanced progressive lenses, might push that figure to £50. The consumer, sitting in the optician's chair, will pay ten or twenty times that amount. "The margins," as one veteran of the eyewear sector once confided to a journalist, choosing his words with the care of a man describing something slightly indecent, "are outrageous."
What makes this fact extraordinary is not merely the spread between cost and price — luxury goods achieve similar ratios — but the universality of the underlying need. Roughly 70% of adults in developed countries require corrective lenses. Presbyopia, the age-related loss of near vision, affects approximately 85% of people over forty, some 826 million worldwide. The global eyewear market exceeds $100 billion. And one company — a Franco-Italian entity born from a 2018 merger between a Parisian lens cooperative and a workshop in the Italian Dolomites — now controls approximately 25% of it. EssilorLuxottica reported €26.5 billion in revenue in 2024, commands a market capitalization that has surged past €125 billion, employs more than 200,000 people, operates roughly 18,000 retail stores, and partners with over 300,000 optical professionals across 150 countries. It manufactures your lenses. It made your frames. There is a reasonable chance it owns the store where you bought them, and in the United States, it may even administer the vision insurance plan that helped you pay.
This is the story of how a product universally associated with human frailty — a prosthetic, really, for a failing organ — became one of the most profitable consumer categories on earth, and how two companies, approaching the same problem from opposite ends of the value chain, came to dominate it so thoroughly that their merger felt less like a corporate transaction than the closing of a circuit.
By the Numbers
The EssilorLuxottica Empire
€26.5BFY2024 revenue
€125B+Market capitalization (early 2025)
~25%Global eyewear market share
200,000+Employees worldwide
~18,000Company-owned stores
150+Proprietary and licensed brands
€4.4BFY2024 adjusted operating profit
~6%Revenue invested in R&D
The Orphan and the Optician
Leonardo Del Vecchio was born on May 22, 1935, in a working-class district of Milan, the youngest of four children. His father, a fruit and vegetable peddler, died five months before his birth. In 1942, with bombs falling on the city and her youngest son living as what she described in a handwritten letter as a child in "complete abandon," his mother Grazia Rocco surrendered him to the Martinitt Institute, Milan's most famous orphanage. He would spend seven years there. At fifteen, he left, writing in his application that his goal was to become "a skilled craftsman" — a path that would ensure he would "never go hungry again" and "never have to answer to anyone but himself."
He apprenticed as a metal engraver and tool-maker, losing part of his left index finger in a factory accident. He worked in a shop that made components for eyeglass frames. And in 1961, at twenty-six, taking advantage of a regional program offering free land to entrepreneurs willing to establish businesses in the depopulating Alpine foothills, Del Vecchio opened a small workshop in Agordo — a village in the Dolomites, about ninety minutes north of Venice — to produce metal parts for other eyewear companies.
The company was called Luxottica.
The other half of the eventual merger had origins that were, in their own way, equally improbable. In 1849, a cooperative association of eyeglass craftsmen formed in Paris — workshops assembling frames, grinding lenses, keeping alive a tradition that stretched back centuries. This collective would evolve through mergers and name changes: Essel, specializing in frames and later lenses, merged in 1972 with Silor, a company founded by Georges Lissac in 1931 that pioneered new lens materials and treatments. The resulting entity — Essilor — would become the world's dominant manufacturer of prescription lenses, acquiring more than 250 companies over two decades and commanding nearly half the global corrective lens market.
Where Del Vecchio understood distribution and desire — the transformation of a medical necessity into a fashion object — Essilor understood optics and precision. The company's signal achievement was the Varilux progressive lens, introduced in 1959, which corrected presbyopia without the visible line of traditional bifocals. It was, in the language of the industry, a "complex lens," the kind that commanded premium prices and required sophisticated manufacturing. Essilor's dominance in this category — the high-margin, high-technology segment of the lens market — would become the foundation of its economic power.
Two companies. Two countries. Two ends of the value chain. Lenses and frames. Science and fashion. It took them more than half a century to find each other.
The Vertical Integrator
Del Vecchio's genius — and it is not too strong a word — was his recognition, from the very beginning, that the eyewear industry's economics rewarded control. Not excellence in any single function, but ownership of the entire chain, from the machining of a hinge to the consumer's hand reaching for her wallet.
Luxottica started as a subcontractor, manufacturing parts for other companies. By 1967, it had begun producing its own complete frames. By the early 1980s, Del Vecchio was expanding internationally, opening distribution subsidiaries and acquiring competitors. But the pivotal insight came in 1988, when Luxottica signed a licensing agreement with Giorgio Armani to design and manufacture eyewear under the Armani name.
This was, in retrospect, the moment the industry changed. Before Armani, eyeglasses carried deep negative associations. Medieval art depicted the devil wearing spectacles; paintings placed glasses alongside skulls as symbols of mortality and decay. People with poor vision genuinely resisted wearing them. The licensing deal — and the dozens that followed, with Bulgari, Chanel, Prada, Valentino, Dolce & Gabbana, Versace, Burberry, Tiffany — did something more profound than add a logo to a frame. It recast the eyeglass as an object of desire. Fashion houses lent their aura; Luxottica provided the manufacturing expertise, the distribution network, and the pricing architecture. Designer frames that cost a few euros to produce could sell for hundreds. The brands won effortless revenue from licensing fees. Luxottica won something more valuable: the right to manufacture, price, and distribute the product.
Then Del Vecchio went after retail.
In 1995, Luxottica acquired U.S. Shoe Corporation — a company five times its size — for $1.4 billion, not because Del Vecchio wanted to sell shoes, but because U.S. Shoe owned LensCrafters, the largest optical retail chain in the United States, with 590 stores. He immediately divested everything except LensCrafters. It was the first time a manufacturer had entered optical retail, and the industry was horrified. A frame-maker now controlled the shelf. In 2001, Luxottica added Sunglass Hut. Later came Pearle Vision, Target Optical, and eventually EyeMed, one of the largest vision insurance providers in the U.S.
The implications were structural. If you walked into a Sunglass Hut and chose between Ray-Ban and Prada, Luxottica won either way. If your EyeMed insurance plan steered you toward certain frames at LensCrafters, Luxottica was the manufacturer, the retailer, and the insurance administrator. It was not merely vertical integration. It was something closer to a closed loop.
I've always strived to be the best at everything I do — that's it. I could never get enough.
The Resurrection of Ray-Ban
In 1999, Luxottica paid $640 million to acquire Bausch & Lomb's eyewear business. The crown jewel was Ray-Ban — a brand that had once defined American cool, its Aviators on the faces of every pilot, its Wayfarers on Audrey Hepburn in
Breakfast at Tiffany's and Tom Cruise in
Top Gun. But by the late 1990s, Ray-Ban was a ruin. Bausch & Lomb had flooded the mass market, selling Ray-Bans for $19 at gas stations and convenience stores.
Quality had collapsed: frames fell apart four times faster than Luxottica's other brands. The tooling was antiquated. The brand had lost its soul.
What Luxottica did with Ray-Ban became the playbook for luxury brand rehabilitation, studied in business schools and feared by competitors.
Phase one was production. In 2000, Luxottica consolidated Ray-Ban manufacturing from four outdated facilities around the world into a single state-of-the-art plant in northeastern Italy — the heart of premium eyewear manufacturing, with its deep talent pool and proximity to the fashion houses of Milan. Quality improved immediately.
Phase two was distribution discipline. Luxottica yanked Ray-Ban from low-end retailers. No more gas stations. No more drugstores. The brand reappeared in optical boutiques, department stores like Nordstrom and Neiman Marcus, and Luxottica's own Sunglass Hut locations — environments where the product could be "romanced," in the industry's telling phrase.
Phase three was pricing. Luxottica raised prices steadily, restoring the brand's premium positioning. A pair of Wayfarers that had sold for $19 climbed past $150, then $200, then $300 at the high end.
The results were staggering. In 2000, Ray-Ban generated €252 million for Luxottica, about 10% of company sales. By 2014, that figure had risen more than eightfold to €2.065 billion — 27% of Luxottica's total revenue. Ray-Ban became the largest sunglasses brand in the world, commanding approximately 5% of the global eyewear market on its own. In 2024, with smart glasses and refreshed designs, the brand remains EssilorLuxottica's most powerful proprietary asset. Ray-Ban recently opened its first-ever flagship store in SoHo, Manhattan — a sleek temple of acetate and glass that would have been unimaginable to anyone who'd seen the brand hawked beside windshield wiper fluid.
The Oakley acquisition in 2007 followed a more ruthless script. When the performance eyewear brand resisted Luxottica's distribution terms, Luxottica pulled Oakley products from Sunglass Hut. Oakley's stock cratered. Luxottica bought the company for approximately $2.1 billion. Del Vecchio was not sentimental about these things.
The Lens King's Quiet Dominance
If Luxottica's story is a narrative of bold acquisitions and brand alchemy — operatic, Italian in its sweep — Essilor's is a different kind of tale. Quieter. More French. Built on science, on incremental improvement, on the relentless accumulation of small advantages that compound into something impregnable.
Essilor's moat was rooted in the prescription lens, and specifically in the complex lens. A "simple" lens corrects a single refractive error — myopia, hyperopia. A "complex" lens — a progressive or multifocal — addresses multiple conditions simultaneously, eliminating the visible line of the old bifocal. These lenses require sophisticated design, precision surfacing, and proprietary coatings. They are also, not coincidentally, far more expensive. The Varilux progressive, invented in 1959, became Essilor's franchise product, the way Coca-Cola's formula is Coca-Cola's franchise — a continually refined formulation that competitors could approximate but never quite match.
Over decades, Essilor executed what might be the most successful roll-up strategy in European industrial history. More than 250 acquisitions in twenty years. Local lens laboratories. Regional distributors. Coating specialists. Each acquisition extended Essilor's network, deepened its relationship with opticians, and made it incrementally harder for competitors to offer a comparable product with comparable service. By the time of the merger with Luxottica, Essilor controlled nearly half of the world's prescription lens market — a share so dominant that the French competition authority, the Autorité de la concurrence, would later fine Essilor International €81 million for discriminatory practices aimed at suppressing online competitors, finding that the company had abused its dominant position over an eleven-year period by refusing to deliver branded lenses to e-commerce operators.
The fine revealed something important about Essilor's power: it was so embedded in the distribution chain — so essential to the optician's ability to fulfill prescriptions — that it could dictate terms. It didn't need to own the retail stores. It owned the product inside them. As Sam Knight wrote in a remarkable investigation for The Guardian: "The lenses in my glasses — and yours too, most likely — are made by Essilor."
The Merger That Closed the Circuit
On January 16, 2017, Essilor and Luxottica announced plans to combine in an all-stock transaction valued at approximately €50 billion. Leonardo Del Vecchio, then eighty-one, would become executive chairman of the combined entity; Hubert Sagnières, Essilor's CEO, would serve as executive vice-chairman and deputy CEO with powers described as equal to Del Vecchio's. The equity would be split roughly 50-50 between each company's shareholders. Both sides insisted it was a "combination," not an acquisition.
It was, on paper, the most logical merger in the history of consumer goods: the world's dominant lens manufacturer combining with the world's dominant frame manufacturer and eyewear retailer. The strategic rationale was almost tautological. Every pair of glasses needs both lenses and frames. Controlling both meant controlling the product. Controlling both plus the retail channel meant controlling the consumer relationship from the darkened exam room to the gleaming display case.
Key milestones in the EssilorLuxottica merger
2013Informal discussions begin between Del Vecchio and Essilor leadership about a potential combination.
Jan 2017Essilor and Luxottica announce merger plans; transaction valued at ~€50 billion.
Oct 2018The merger closes. EssilorLuxottica begins trading on Euronext Paris.
2019-2020Bitter power struggle erupts between Italian and French camps over governance and integration.
Dec 2020Francesco Milleri appointed CEO. Integration accelerates under unified leadership.
Jun 2022Leonardo Del Vecchio dies at 87. Milleri assumes chairmanship.
The reality was considerably messier. What followed the merger's completion in October 2018 was a protracted, sometimes vicious governance battle between the Italian and French factions. Del Vecchio and Sagnières clashed over authority, over integration plans, over the very nature of the entity they had created. The "merger of equals" framework — a structure that has destroyed more value in corporate history than perhaps any other — threatened to paralyze the company. Two headquarters. Two cultures. Two CEOs who regarded each other with mounting suspicion.
The resolution came, as it so often does in founder-led companies, through the force of personality. Del Vecchio, then in his mid-eighties, reasserted control. By December 2020, Francesco Milleri — Del Vecchio's closest aide, a Florentine-born lawyer and business consultant who had worked alongside the founder for years — was appointed sole CEO. Sagnières was out. The French camp had lost the power struggle, though Essilor's operational expertise remained central to the combined entity.
Milleri had graduated with honors in law from the University of Florence, earned an MBA from Bocconi, and completed a specialization in corporate finance at NYU's Stern School of Business on a scholarship from the Banca d'Italia. He had spent years as a consultant before founding a technology company, then joined Del Vecchio's orbit. He was, in temperament, Del Vecchio's opposite — quietly analytical where the founder was viscerally competitive — but he shared the founder's conviction that vertical integration was not merely a strategy but an identity.
The Succession Question
On June 27, 2022, Leonardo Del Vecchio died in Milan at the age of eighty-seven. Italy's second-richest man, worth tens of billions of euros, he had never retired. He had, if anything, intensified his business activities in his final decade — sealing the Essilor merger, orchestrating the governance resolution, acquiring stakes in Italian financial institutions Mediobanca and Generali through his holding company Delfin. Former employees recalled him getting involved with even trivial matters in his later years — telling staff how to pack boxes for an office move. He could never get enough.
His death created a succession challenge that remains unresolved as of early 2026. Del Vecchio's six children from three relationships, plus his fourth wife Nicoletta Zampillo, inherited stakes in Delfin, the Luxembourg-based holding company that controls approximately 32% of EssilorLuxottica's shares. Delfin's chairmanship passed to Milleri. But the heirs have not finalized a succession agreement. Tensions between them have spilled into the Italian press — most recently between Rocco Basilico, Zampillo's son from a previous marriage (who served as EssilorLuxottica's chief wearables officer until his departure in January 2026), and Leonardo Maria Del Vecchio, the founder's youngest son and current president of the Ray-Ban brand.
The dynastic complexity is a mirror of Italian capitalism itself: family wealth concentrated in holding structures, governance shaped by personal relationships as much as corporate bylaws, succession treated as a problem to be deferred rather than solved. Delfin's 32% stake gives the family effective control. How they choose to exercise it — and whether they can agree on how to exercise it — will shape EssilorLuxottica's governance for a generation.
Most octogenarians would, given the opportunity, rush to the sun lounger in Monaco.
The Product That Is Also a Platform
EssilorLuxottica's most intriguing strategic bet is not a pair of glasses. It is the idea that a pair of glasses could become the next computing platform.
In 2019, Luxottica partnered with Meta Platforms (then Facebook) to develop smart eyewear. The first product, Ray-Ban Stories, launched in 2021 to modest reception. The second generation — Ray-Ban Meta, launched in late 2023 — was a different matter entirely. Equipped with cameras, speakers, a microphone, and Meta's AI assistant, the Ray-Ban Meta glasses looked and felt like normal Ray-Bans. They weighed only slightly more. They could take photos, make calls, play music, livestream to social media, translate conversations in real time, and answer questions through Meta AI. They were, by the standards of previous smart glasses attempts (Google Glass, Snap Spectacles), a genuine consumer product rather than a technology demonstration.
By the end of 2024, EssilorLuxottica had sold 2 million pairs of Ray-Ban Meta since launch, with strong acceleration in the second half of the year. The partnership generated an estimated €365 million in revenue for EssilorLuxottica in 2024. Barclays projects this could reach €800 million in 2025 and, in its most optimistic scenario, more than €6 billion by 2030. Milleri has said the company is expanding production capacity to 10 million units annually by the end of 2026.
Meta, for its part, has invested approximately $3.5 billion to acquire just under 3% of EssilorLuxottica's equity, with reported plans to build its stake to around 5%. It is a remarkable validation: the world's largest social media company buying a minority position in the world's largest eyewear manufacturer because it believes that glasses — not headsets, not wristbands, not phones — will be the primary interface for artificial intelligence.
"Glasses, which have long been seen as prosthetics and later as fashion accessories, are poised to become the central device in people's lives, possibly replacing smartphones," Milleri said in a rare interview on Bloomberg's Italian-language podcast in late 2025. "We could foresee in the near future hundreds of millions of smart glasses interconnected with each other."
This is an extravagant claim. But the underlying logic is sound in its dimensions: EssilorLuxottica already sells hundreds of millions of frames annually. Its retail network, its manufacturing base, its optical expertise, and its consumer relationships constitute an unmatched distribution system for any wearable technology that sits on the face. If smart glasses become a mass consumer category — and Apple, Google, Samsung, and Chinese competitors are all developing their own — EssilorLuxottica's position as the manufacturer of choice is defensible in ways that pure technology companies cannot replicate. You can write the software. But someone has to make the glasses comfortable, fashionable, and optically precise. And no one does that at EssilorLuxottica's scale.
The Supreme Aberration
On July 17, 2024, EssilorLuxottica announced the acquisition of Supreme — the streetwear label founded by James Jebbia in 1994 on Lafayette Street in downtown Manhattan — from VF Corporation for $1.5 billion in cash.
The deal baffled analysts. Supreme is not an eyewear brand. It is a skateboarding-born streetwear cult with 17 stores, a digital-first business model, and a brand identity built on drops, scarcity, and collaborations with Louis Vuitton and The North Face. What did this have to do with lenses and frames?
The answer, as Milleri and Deputy CEO Paul du Saillant explained, was about audience and platform. "We see an incredible opportunity in bringing an iconic brand like Supreme into our Company," they said. "It perfectly aligns with our innovation and development journey, offering us a direct connection to new audiences, languages and creativity." Supreme's customer base skews young, urban, and deeply engaged with the intersection of fashion and technology — precisely the demographic EssilorLuxottica needs for smart glasses adoption.
Supreme also represents a test of a broader thesis: that EssilorLuxottica is not merely an eyewear company, or even a vision care company, but a consumer platform — a "house of brands" model analogous to LVMH or Kering, but anchored in the face rather than the wardrobe. The company already holds licensing agreements with virtually every major luxury and fashion house in the world. The addition of Supreme — alongside the 2024 acquisition of an 80% stake in Heidelberg Engineering, a German manufacturer of diagnostic instruments for clinical ophthalmology — suggests a company that is simultaneously reaching deeper into medical technology and wider into consumer culture.
Whether this is strategic brilliance or conglomerate hubris will not be clear for years. But the $1.5 billion price tag, and the decisiveness with which it was executed, signals that Milleri's EssilorLuxottica is not interested in being defined by the categories it inherited.
The Machine Behind the Magic
The choreography of selling eyeglasses — what the industry calls "romancing the product" — begins in a darkened room, where you contemplate blurred letters and the quiet deterioration of your visual cortex. It ends in a bright, gallery-like space, where you enjoy the feel of acetate between your fingers, listen to what you're told, pay more than you expected, and look forward to inhabiting a slightly sharper version of yourself.
The "capture rate" — the percentage of eye exams that convert into eyewear purchases — is typically around 60% at most opticians. EssilorLuxottica's vertically integrated model is designed to maximize every link in this chain. Its Professional Solutions division supplies lenses, frames, instruments, and digital services to the hundreds of thousands of independent opticians who depend on its products. Its Direct-to-Consumer division — LensCrafters, Sunglass Hut, Pearle Vision, OPSM, Salmoiraghi & Viganò, and a growing e-commerce platform — captures the sale directly. In both channels, EssilorLuxottica controls the product, the pricing, and increasingly, the technology that connects them.
The company invests approximately 6% of revenue in R&D — roughly €1.6 billion annually — a figure that exceeds the entire revenue of most competitors. Its labs are developing next-generation progressive lenses that use behavioral AI to adapt to individual gaze patterns, Stellest lenses for myopia management in children (up approximately 50% in revenue in Q4 2024 in China alone), and Nuance Audio — FDA-cleared and EU-certified glasses that integrate hearing assistance directly into premium eyewear frames.
From med-tech to wearables, we are driving the future. With our iconic brands, we continue to earn the loyalty of consumers and accelerate technological adoption.
The vision — and Milleri uses this word with full awareness of the pun — is that the human eye will become "the most seamless and immediate bridge between human intelligence and AI, between reality and the digital world." The company that once made spectacle hinges in an Alpine workshop now describes itself, without irony, as a med-tech company.
A Monopoly Hidden in Plain Sight
Kerry Segrave's
Vision Aids in America: A Social History of Eyewear and Sight Correction Since 1900 documents how the American eyewear industry was, for most of the twentieth century, fragmented, local, and professionally controlled — opticians and ophthalmologists serving patients, not consumers, in a market where advertising was considered unseemly and brand loyalty was almost nonexistent. What Del Vecchio understood, and what the combination with Essilor completed, was the transformation of this medical backwater into a consumer category with the margins of luxury goods and the recurring demand of healthcare.
The result is a company whose competitive position has few true parallels. LVMH dominates luxury goods, but it competes with Kering, Richemont, Hermès, and dozens of independent houses. Google dominates search, but faces regulatory pressure and emerging AI competition. EssilorLuxottica dominates eyewear at every level of the value chain simultaneously — lenses, frames, brands, retail, insurance, and now technology — in a market where 70% of the adult population are potential customers and penetration in emerging markets remains low.
The company's critics — and there are many, particularly among independent opticians who feel squeezed by its pricing power and distribution control — argue that this dominance is unhealthy. The French competition authority's €81 million fine for discriminatory practices against online lens retailers is the most tangible evidence that regulators agree. Warby Parker, the direct-to-consumer eyewear brand that went public in 2021, built its entire identity on the promise of disrupting the EssilorLuxottica oligopoly — but Warby Parker's total annual revenue remains a fraction of EssilorLuxottica's, and its losses suggest the economics of competing with a vertically integrated incumbent are more punishing than its Silicon Valley backers anticipated.
The deeper question is whether EssilorLuxottica's dominance is the product of anticompetitive behavior or simply the natural outcome of a business where vertical integration, brand portfolio depth, and manufacturing scale create self-reinforcing advantages that no entrant can replicate at a competitive cost. The answer, almost certainly, is both. And that ambiguity — the moat that is also the antitrust risk, the scale that enables innovation and forecloses competition simultaneously — is the defining tension of the business.
In the lobby of EssilorLuxottica's Milan headquarters, there is a showroom displaying the company's brands: Ray-Ban, Oakley, Persol, Oliver Peoples, Varilux, Transitions, Stellest, Nuance Audio, Ray-Ban Meta. Over 150 brands in total, from mass-market to haute couture. The room is bright, gallery-like. You enjoy the feel of acetate between your fingers. You pay more than you expected. And somewhere, in the economics of the thing, a workshop in Agordo is still making spectacle parts — just at a scale that its orphan-founder, arriving on a Lambretta in 1961, could not possibly have imagined.
